Immutep Quote - IMM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.32

Bid

0.32

Ask

0.325

Volume

7,323,798

0.315 Day's Range 0.33

0.23 52 Week Range 0.485

Market Cap

281.309M

Previous Close

0.325

Open

0.325

Last Trade

2000000

0.32

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

2,751,688

Shares Outstanding

879,089,453

Dividend Yield

PE Ratio

-6.58

Earnings Per Share (EPS)

-0.05

Revenue

Net Profit

-42.72M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.immutep.com

Headquarters

Sydney, New South Wales, Aus

Founded

Immutep Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker IMM. The last closing price for Immutep was AUD0.33. Over the last year, Immutep shares have traded in a share price range of AUD 0.23 to AUD 0.485.

Immutep currently has 879,089,453 shares outstanding. The market capitalization of Immutep is AUD285.70 million. Immutep has a price to earnings ratio (PE ratio) of -6.58.

Immutep Has Successful Type C Meeting With FDA

By Chris Wack Immutep Ltd. said Friday it had a successful Type C meeting with the U.S. Food and Drug Administration regarding late-stage clinical development plans for its first-in-class soluble...

Immutep Gets Fast Track Designation for Eftilagimod Alpha Cancer Treatment

By Chris Wack Immutep Ltd. said Tuesday that the U.S. Food and Drug Administration granted fast track designation to eftilagimod alpha IMP321 in combination with pembrolizumab for the treatment of...

Immutep in Collaboration, Supply Agreement With Merck KGaA

By Chris Wack Immutep Limited is in a new collaboration and supply agreement with Merck KGaA, Darmstadt, Germany, for a Phase I/IIa clinical trial in patients with solid tumors. The biotechnology...

Immutep Says Interim Phase II TACTI-002 Data Positive

By Michael Dabaie Immutep Ltd. said interim data was positive from its ongoing Phase II TACTI-002 study. ADRs were down 1% to $3.00 premarket. The data relates to use of the company's lead...

Immtech to be Listed on OTC Market

NEW YORK, May 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (OTC:IMMP) announced today that the Company expects to begin trading its common stock on the Pink OTC Markets quotation...

Immtech to Reorganize Research and Development Operations

NEW YORK, April 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that the Company is reorganizing its R&D operations. This restructuring will direct...

Immtech Announces Investment in China

NEW YORK, April 3 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that it has made an investment in Gold Avenue Ltd., a privately-held Hong Kong company...

Immtech Receives Listing Determination Letter

NEW YORK, April 2 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE AMEX: IMM) today announced that on March 27, 2009, the Company received notice from the NYSE Amex LLC (the...

Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has signed a Memorandum of Understanding (MOU) confirming...

Immtech To Reschedule Quarterly Conference Call

NEW YORK, Feb. 13 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM) announced today that the Company will postpone the quarterly update conference call scheduled...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.01	-3.0303030303	0.33	0.3325	0.315	914963	0.32340779	DE
4	-0.01	-3.0303030303	0.33	0.37	0.315	1189412	0.34197585	DE
12	0.025	8.47457627119	0.295	0.385	0.27	2751688	0.3215056	DE
26	0.035	12.2807017544	0.285	0.415	0.27	3328555	0.33194004	DE
52	-0.05	-13.5135135135	0.37	0.485	0.23	3161483	0.35188197	DE
156	-0.115	-26.4367816092	0.435	0.485	0.225	1856698	0.3393868	DE
260	0.02	6.66666666667	0.3	0.725	0.1	2110304	0.36717491	DE

IMM - Frequently Asked Questions (FAQ)

What is the current Immutep share price?

The current share price of Immutep is AUD 0.32

How many Immutep shares are in issue?

Immutep has 879,089,453 shares in issue

What is the market cap of Immutep?

The market capitalisation of Immutep is AUD 285.7M

What is the 1 year trading range for Immutep share price?

Immutep has traded in the range of AUD 0.23 to AUD 0.485 during the past year

What is the PE ratio of Immutep?

The price to earnings ratio of Immutep is -6.58

What is the reporting currency for Immutep?

Immutep reports financial results in AUD

What is the latest annual profit for Immutep?

The latest annual profit of Immutep is AUD -42.72M

What is the registered address of Immutep?

The registered address for Immutep is LEVEL 12, 95 PITT STREET, SYDNEY, NEW SOUTH WALES, 2000

What is the Immutep website address?

The website address for Immutep is www.immutep.com

Which industry sector does Immutep operate in?

Immutep operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WHKOWhiteHawk Limited	AUD 0.002 (100.00%)	462.22k
3DPPointerra Limited	AUD 0.07 (42.86%)	37.78M
AVMOAdvance Metals Ltd	AUD 0.02 (42.86%)	554.75k
ASEAstute Metals NL	AUD 0.034 (41.67%)	1.13M
L1MOLightning Minerals Ltd	AUD 0.015 (36.36%)	118.6k
BPHOCommon Stock	AUD 0.001 (-50.00%)	28.01M
MMROMEC Resources Ltd	AUD 0.001 (-50.00%)	15.33M
NCCONAOS Emerging Opportunities Company Limited	AUD 0.003 (-40.00%)	10.27k
MMRMEC Resources Ltd	AUD 0.003 (-40.00%)	6.39M
ACWOCActinogen Medical Limited	AUD 0.008 (-38.46%)	2.25M
1TTThrive Tribe Technologies Ltd	AUD 0.004 (14.29%)	83.33M
SGRStar Entertainment Group Limited	AUD 0.115 (-17.86%)	80.86M
3DPPointerra Limited	AUD 0.07 (42.86%)	37.78M
OVTOvanti Ltd	AUD 0.02 (-9.09%)	34.97M
ATHAlterity Therapeutics Ltd	AUD 0.0085 (0.00%)	32.68M